Article 25 substantial-modification assessment
Compute ratio (tuning compute / upstream compute), intended-use diff, risk-profile diff. Written conclusion on provider/deployer status under EU AI Act Article 25.
Fine-tuning is a compliance event, not just an engineering one. It shifts liability allocation, triggers new disclosures, and in the EU can flip a deployer into a provider with full GPAI obligations. We name the laws, the dated deadlines, and the 20 controls that keep an enterprise fine-tune defensible in audit.
EU AI Act Article 25: a deployer becomes a provider when they (a) put their name or trademark on a high-risk system, (b) make a substantial modification that keeps it high-risk, or (c) modify intended purpose so the system becomes high-risk. For GPAI, the Commission's July 2025 Guidelines set 'significant modification' at one-third of the upstream training compute. Most enterprise LoRA fine-tunes are nowhere near that threshold, but rebranding alone flips you. We run the assessment in week one. It is the cheapest control on this page.
From California AB 2013 (training-data summary, January 2026) to the EU AI Act full enforcement (August 2027). Each row is dated, each is sourced, each is on our re-validation cycle.
Fourteen regions, the headline law, and the controls that actually bite for a fine-tuned LLM. Where a law is in flux (Brazil PL 2338, Canada AIDA replacement), we flag the status.
Where a law is in flux (Brazil PL 2338, Canada AIDA replacement), the status is flagged.
| Region | Headline law | Must-have for fine-tuners |
|---|---|---|
EU | AI Act 2024/1689 | Article 25 substantial-modification assessment, Annex IV technical doc, training-data public summary (GPAI), Article 50 output marking, GDPR Art 35 DPIA, EDPB Opinion 28/2024 anonymity assessment, ISO 42001 increasingly required |
US (federal) | NIST AI RMF + sectoral | NIST AI RMF + Gen AI Profile (600-1) alignment, FedRAMP if government sales, sectoral (HIPAA / FDA / SEC / FINRA), SOC 2 Type II |
US (CA) | AB 2013 + SB 53 + SB 942 | Training-data public summary (Jan 2026), Frontier Framework + incident reporting if >10^26 FLOPs (Jan 2026), detection tool + C2PA provenance (Aug 2026) |
US (CO + NY + IL) | Colorado AI Act + NYC LL144 + IL HB 3773 | High-risk AI impact assessment + risk policy + consumer notice (CO, Jun 2026), annual bias audit + LL144 candidate notice (NYC), AI employment notice (IL, Jan 2026) |
UK | ICO AI guidance + PRA SS1/23 | ICO AI + ADM compliance + DPIA, PRA SS1/23 model risk for finance, AISI Inspect for frontier deployments, sectoral regulator engagement |
Canada | PIPEDA + Quebec Law 25 + OSFI E-23 | PIPEDA + Quebec ADM notice and human review, ISED Voluntary Code (if signatory), OSFI E-23 for FRFIs (May 2027) |
India | DPDP Act + MeitY | DPDP consent + notice framework (May 2027), MeitY synthetic-media labelling, sectoral RBI and SEBI MRM guidance |
Singapore | PDPA + GenAI Governance Framework | PDPA AI advisory alignment, Model AI Governance Framework adoption, AI Verify testing, MAS Veritas for finance |
UAE + KSA | PDPL + SDAIA Guidelines | Regional PDPL compliance, SDAIA AI Ethics + GenAI Guidelines, ISO 42001 increasingly required for government tenders |
China | GenAI Measures + Algorithm Filing | CAC algorithm filing + GenAI security assessment (public-facing), real-name auth, output labelling, training-data lawfulness review |
Japan | APPI + AI Promotion Act | APPI compliance, AI Promotion Act cooperation, METI Guidelines for Business adherence |
Korea | PIPA + AI Basic Act | PIPA compliance, AI Basic Act high-impact obligations (Jan 2026), mandatory GenAI output labelling |
Australia | Privacy Act + AI Safety Standard | APP 1.7-1.9 ADM transparency (Dec 2026), Voluntary AI Safety Standard guardrails, OAIC GenAI guidance |
Brazil | LGPD + PL 2338 (pending) | LGPD compliance, ANPD AI guidance, PL 2338 readiness (Senate-approved, Chamber pending) |
Healthcare, finance, public sector + defense, critical infrastructure. The four verticals where a fine-tune draws the most distinct compliance burden across regions.
The four verticals where a fine-tuned LLM draws the most distinct compliance burden across regions.
| Vertical | US | EU | UK | Asia |
|---|---|---|---|---|
Healthcare | HIPAA + FDA AI/ML SaMD + PCCP + ONC HTI-1 + state | MDR/IVDR + GDPR Art 9 + AI Act high-risk Annex III | MHRA SaMD + UK GDPR | Local health data laws, DPDP health-data consent (IN), PDPA (SG) |
Finance | SEC/FINRA supervision + sectoral MRM + state laws | DORA + MiFID II + AI Act Annex III (credit scoring, insurance) | PRA SS1/23 + FCA Mills Review | MAS FEAT + Veritas (SG), RBI + SEBI (IN), JFSA (JP), FSC (KR) |
Public + defense | FedRAMP Mod/High + DoD IL4/5/6 + ITAR/EAR + NIST AI RMF | AI Act limited defense exemption + GDPR | OSA + DSIT Blueprint + AISI evaluations | Sovereign cloud + national procurement laws |
Critical infrastructure | CIRCIA + NIST CSF 2.0 + sectoral (NERC CIP, TSA) | NIS2 + Cyber Resilience Act + AI Act high-risk | NIS Regulations 2018 (as amended) | Critical Information Infrastructure laws (SG, IN) |
Each is grounded in an actual law or framework citation. We ship a customised version with every engagement; this is the base list.
Compute ratio (tuning compute / upstream compute), intended-use diff, risk-profile diff. Written conclusion on provider/deployer status under EU AI Act Article 25.
Populated using the AI Office template (July 24, 2025) for any GPAI-class model.
Public-website disclosure for any GenAI released since January 1, 2022 serving California users.
Intended use, training and tuning data summary, evaluation results, known limitations, copyright posture.
End-to-end deployment context, guardrails, incident channels.
Mandatory if processing involves systematic and extensive evaluation, large-scale special category data, or large-scale monitoring.
Documented 'negligible probability' analysis or fall back to lawful basis under Article 6 (typically legitimate interest with three-part balancing test).
Documented Article 17 handling, with Article 17(3) proportionality memo where unlearning is infeasible. Plan periodic retrain on cleaned corpus.
Per dataset: source, acquisition method, licensing, PII flag, copyright posture, robots.txt + TDM opt-out check, contract reference.
C2PA v2.3 manifests + SynthID-class invisible watermark + visible disclosure. EU AI Act Article 50 (Aug 2026), China GenAI Measures, California SB 942 (Aug 2026).
Annex VI (internal control) or Annex VII (notified body); EU Declaration of Conformity; CE marking for high-risk.
Independent annual audit (NYC LL144, Illinois SB 315, Colorado AI Act, EU AI Act Article 10). Protected-class testing methodology documented.
AISI Inspect or equivalent harness; NIST ARIA; EU AI Act Article 15 (high-risk) and Article 55 (GPAI systemic risk).
Sigstore / in-toto attestations per training run. Dataset hash maps to checkpoint hash maps to inference endpoint.
For EU customers, weights at rest under customer-controlled KMS in EU region.
EU SCCs + TIA per Schrems II; UK IDTA; India DPDP cross-border rules; UAE Article 23 PDPL.
Weights, tuning infra, inference plane, prompt logs all inside the authorization boundary. Plan of Action and Milestones for inherited controls.
Establish and certify; covers ~70% of EU AI Act high-risk documentation; increasingly demanded in Saudi, UAE, Singapore tenders.
EU AI Act Article 73 (serious incident reporting), G7 HAIP framework, NIS2 (24h early warning, 72h notification), CIRCIA (US), California SB 53 (critical incidents to OES).
Single source of truth: every tuned variant with owner, intended use, validation status, monitoring, approval signature, deployment scope. Required by PRA SS1/23, OSFI E-23, MAS FEAT, RBI guidance, SEC/FINRA expectations.
AI management system. The dominant cert in 2026. ~70% of EU AI Act high-risk doc requirements. Mandatory in many SA / UAE / SG tenders.
AICPA TSC 2017. Required by most enterprise buyers. Apply to training pipeline, model registry, eval harness, inference plane.
April 2025 release maps to NIST AI RMF v1.0 + ISO 23894. 51 AI risk management control requirements. Best for healthcare + federal.
Required for US federal sales. 12 to 18 months from kickoff. Boundary doc must include the model training environment + inference plane.
SFT, LoRA, QLoRA, DoRA, DPO, SimPO, ORPO, KTO, GRPO/RFT, distillation, model merging. Every named technique with when it earns the build.
Read moreSourcing, PII redaction (Presidio), synthetic data (Distilabel, Nemotron), DEITA quality scoring, MinHash + SemDedup, labeling vendors, feedback loops.
Read moreOpenAI RFT, Anthropic on Bedrock, Vertex, Azure Foundry, Databricks Mosaic, Together, Predibase, NeMo Customizer, Modal, Lambda. Side-by-side with our take.
Read moreUnder 1k examples to over 1M, single A10G to 128 B200. Indicative cost, recommended method, hardware tier.
Read moreContinued pretraining, SFT, preference optimization (DPO, SimPO, ORPO), reasoning distillation (R1 lineage), model merging (TIES, DARE). The full build pipeline.
Read more